The stock market is down Wednesday, with the Dow Jones Industrial Average down 0.12%, the Nasdaq down 0.76% and the S&P 500 down 0.42%. Today’s only winner is a pharmaceutical company that has been in correction for the past two days. Meanwhile, one of today’s losers had a subsidiary that withdrew an initial public offering, while another loser is a pharmaceutical company that delayed publishing the results of a study.
These are Wednesday’s market winner and losers.
Shares of Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) are up 6.45% to $1.81 on trading volume of 11.9 million shares. Shares have rebounded for the last two days after the stock price lost the majority of its value Monday after discrepancies with a lung cancer drug test. The 52-week high is $5.50.
Shares of Blyth Inc. (NYSE: BTH) are down 16.64% to $27.15 on trading volume of 1.4 million shares. ViSalus, a subsidiary of Blyth that sells nutritional supplements, withdrew its proposed IPO due to market uncertainty. The 52-week low is $25.62.
Shares of Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) are down 10.76% to $1.64 on trading volume of 2.9 million shares. The mid-stage results of a cocaine addiction study were delayed. The 52-week low is 50 cents.
Follow him on Twitter: SWeigley